Wesbanco Bank Inc. Has $1.16 Million Stock Position in Phreesia, Inc. (NYSE:PHR)

Wesbanco Bank Inc. grew its stake in shares of Phreesia, Inc. (NYSE:PHR) by 76.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,000 shares of the company’s stock after acquiring an additional 20,000 shares during the period. Wesbanco Bank Inc. owned 0.08% of Phreesia worth $1,157,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the company. Versor Investments LP bought a new position in Phreesia during the third quarter worth about $694,000. Zacks Investment Management acquired a new stake in shares of Phreesia in the third quarter valued at approximately $631,000. Sei Investments Co. boosted its stake in shares of Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after buying an additional 95,058 shares during the period. State Street Corp grew its position in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after buying an additional 88,517 shares in the last quarter. Finally, Barclays PLC increased its stake in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after acquiring an additional 43,225 shares during the period. Institutional investors own 92.10% of the company’s stock.

Insider Activity

In related news, Director Michael Weintraub sold 15,152 shares of Phreesia stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the transaction, the director now owns 242,827 shares in the company, valued at $5,101,795.27. This trade represents a 5.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total transaction of $86,955.60. Following the sale, the general counsel now owns 116,296 shares of the company’s stock, valued at approximately $2,893,444.48. The trade was a 2.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 131,756 shares of company stock worth $3,244,909. 5.80% of the stock is currently owned by insiders.

Phreesia Trading Up 0.2 %

Shares of PHR opened at $27.26 on Friday. The firm has a market cap of $1.58 billion, a P/E ratio of -18.55 and a beta of 0.94. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The business has a 50-day moving average of $23.87 and a 200 day moving average of $22.97.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same period last year, the company earned ($0.58) earnings per share. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PHR. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. KeyCorp raised their target price on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Truist Financial upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Finally, Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of “Buy” and a consensus target price of $31.00.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.